TCM
IRWD icon

Tekla Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Tekla Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-917,052
Closed -$9.26M – 165
2015
Q2 		$9.26M Hold
917,052
– – 0.34% 66
2015
Q1 		$12.3M Hold
917,052
– – 0.49% 50
2014
Q4 		$11.8M Hold
917,052
– – 0.55% 43
2014
Q3 		$9.95M Hold
917,052
– – 0.47% 42
2014
Q2 		$11.8M Hold
917,052
– – 1.08% 24
2014
Q1 		$9.46M Hold
917,052
– – 0.95% 29
2013
Q4 		$8.92M Hold
917,052
– – 0.94% 27
2013
Q3 		$9.1M Hold
917,052
– – 1.01% 28
2013
Q2 		$7.64M Buy
+917,052
New +$11.1M 1.04% 30

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Tekla Capital Management's IRWD Position: Q3 2015 in Review

Tekla Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2015, closing a stake of 917,052 shares — an estimated $9.26M sold.

Tekla Capital Management first reported a position in IRWD in Q2 2013 and held it in 9 quarters. The position peaked at $12.3M in Q1 2015. 130 funds tracked by Wall St. Rank hold IRWD as of Q3 2015.

  • Tekla Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Tekla Capital Management sold 917,052 Ironwood Pharmaceuticals shares in Q3 2015, an estimated $9.26M.
  • Tekla Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Tekla Capital Management's Ironwood Pharmaceuticals position peaked at $12.3M in Q1 2015.
  • 130 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2015.

Based on Tekla Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.